InsiderClue
Insiders · Profile

Cadavid Diego

Chief Medical Officer at X4 Pharmaceuticals · SVP Clinical Development at Fulcrum Therapeutics. Filing since 3 Feb 2020. CIK 0001778713

XFOR X4 Pharmaceuticals, Inc Chief Medical Officer · 1 trade FULC Fulcrum Therapeutics, Inc. SVP Clinical Development · 12 trades
Company
Date
Role
Action
Shares
Amount
Of holding
XFOR X4 Pharmaceuticals, Inc
11 Feb 2022
Chief Medical Officer
Sold, plan not stated
928
no price
11.5%
FULC Fulcrum Therapeutics, Inc.
1 Jul 2020
SVP Clinical Development
Sold, plan not stated
1,071
$19.60K
1.6%
FULC Fulcrum Therapeutics, Inc.
25 Jun 2020
SVP Clinical Development
Sold, plan not stated
1,459
$32.10K
2.1%
FULC Fulcrum Therapeutics, Inc.
10 Jun 2020
SVP Clinical Development
Sold, plan not stated
401
$8.82K
0.6%
FULC Fulcrum Therapeutics, Inc.
5 Jun 2020
SVP Clinical Development
Sold, plan not stated
451
$9.10K
0.7%
FULC Fulcrum Therapeutics, Inc.
4 Jun 2020
SVP Clinical Development
Sold, plan not stated
226
$4.53K
0.3%
FULC Fulcrum Therapeutics, Inc.
3 Jun 2020
SVP Clinical Development
Sold, plan not stated
338
$6.82K
0.5%
FULC Fulcrum Therapeutics, Inc.
2 Jun 2020
SVP Clinical Development
Sold, plan not stated
45
$900.00
0.1%
FULC Fulcrum Therapeutics, Inc.
29 May 2020
SVP Clinical Development
Sold, plan not stated
200
$4.01K
0.3%
FULC Fulcrum Therapeutics, Inc.
28 May 2020
SVP Clinical Development
Sold, plan not stated
600
$12.00K
0.9%
FULC Fulcrum Therapeutics, Inc.
12 May 2020
SVP Clinical Development
Sold, plan not stated
1,860
$33.48K
2.7%
FULC Fulcrum Therapeutics, Inc.
2 Mar 2020
SVP Clinical Development
Sold, plan not stated
2,143
$37.25K
3.1%
FULC Fulcrum Therapeutics, Inc.
3 Feb 2020
SVP Clinical Development
Sold, plan not stated
2,143
$37.14K
3.0%
13 decisions on file.